All In MedTech

Device Trial Radar · NCT05818098

Coronary Intravascular Lithotripsy System in Patients With Coronary Artery Calcification (VIGOUR)

A Prospective, Multicenter Clinical Trial in Evaluating the Safety and Efficacy of the Intravascular Lithotripsy System in Patients With Coronary Artery Calcification

Last checked: Nov 20, 2026Latest source record: Aug 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

189

Actual

Start

Mar 29, 2023

Primary completion

Sep 15, 2023

Study completion Sep 15, 2023

Sponsor

Lead sponsor
Shanghai MicroPort Rhythm MedTech Co., Ltd.Not on our public-company list
Sponsor type
Industry
Collaborators
The Second Affiliated Hospital of Harbin Medical University; Huai'an First People's Hospital; People's Hospital of Xinjiang Uygur Autonomous Region; First Affiliated Hospital Xi'an Jiaotong University; West China Hospital; Wuhan Central Hospital; First Hospital of China Medical University; Shanxi Bethune Hospital; Hebei Provincial People's Hospital; The Second Hospital of Hebei Medical University; Shanxi Cardiovascular Hospital; Shengjing Hospital; Three Gorges Hospital of Chongqing University; The First Hospital of Jilin University; Xiamen Cardiovascular Hospital, Xiamen University; The People's Hospital of Liaoning Province; Shanghai East Hospital; Linfen No.4 People's Hospital
First posted
Apr 18, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective and multicenter clinical investigation aiming to evaluate the safety and effectiveness of coronary intravascular lithotripsy system for the treatment of patients with coronary calcification.

Conditions

  • Coronary Artery Calcification

Interventions

  • Intravascular Lithotripsy System of Shanghai MicroPort RhythmDevice

    The Intravascular Lithotripsy System is a single-use, sterile, disposable balloon angioplasty catheter that contains a series of unfocused, electrohydraulic lithotripsy emitters, which convert electrical energy into transient acoustic circumferential pressure pulses that disrupt both superficial and deep calcium within vascular plaque.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Procedure success rateTime frame: During hospitalization (up to 7 days after procedure)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The Second Affliated Hospital Ha'erbin Medical University

    Harbin, Heilongjiang, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.